Evidence map›Paper›PMID 33634770›Full record

ReviewPsychological medicine2021

Genetic contributions to autism spectrum disorder.

A Havdahl, M Niarchou, A Starnawska, M Uddin, C van der Merwe, V Warrier

Open access · hybridAbstract readReview
In one paragraph

Review in Psychological medicine, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 103 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
103citing papers in PubMed, 1 pooled it
12.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

103 citing papers in PubMed, 1 synthesis or guideline pooled it, 165 citations in OpenAlex.

  1. Pooled it
  2. Autologous cord bloodWorld journal of clinical pediatrics · 2025
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder.The Journal of clinical endocrinology and metabolism · 2026
    Article
  9. Review
  10. Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Article
  20. Article

43 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 5 countries.

A HavdahlNic Waals Institute, Lovisenberg Diaconal Hospital, Oslo, Norway.ORCID 0000-0002-9268-0423
M NiarchouVanderbilt Genetics Institute, Vanderbilt University Medical Center, TN, USA.
A StarnawskaThe Lundbeck Foundation Initiative for Integrative Psychiatric Research, iPSYCH, Denmark.
M UddinCollege of Medicine, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, UAE.
C van der MerweStanley Center for Psychiatric Research, The Broad Institute of MIT and Harvard, MA, USA.
V WarrierDepartment of Psychiatry, Autism Research Centre, University of Cambridge, UK.
Aarhus University · DKBroad Institute · USMohammed Bin Rashid University of Medicine and Health Sciences · AENorwegian Institute of Public Health · NOUniversity of Cambridge · GBVanderbilt University Medical Center · US

Funding

Phenotypic profiling of ASD riskR01MH111813 · NIMH · BROAD INSTITUTE, INC. · PI ROBINSON, ELISE B · 2017 to 2021
$2.4M
NIMH NIH HHS R01 MH111813
6 · The paper itself

Abstract

Autism spectrum disorder (autism) is a heterogeneous group of neurodevelopmental conditions characterized by early childhood-onset impairments in communication and social interaction alongside restricted and repetitive behaviors and interests. This review summarizes recent developments in human genetics research in autism, complemented by epigenetic and transcriptomic findings. The clinical heterogeneity of autism is mirrored by a complex genetic architecture involving several types of common and rare variants, ranging from point mutations to large copy number variants, and either inherited or spontaneous (de novo). More than 100 risk genes have been implicated by rare, often de novo, potentially damaging mutations in highly constrained genes. These account for substantial individual risk but a small proportion of the population risk. In contrast, most of the genetic risk is attributable to common inherited variants acting en masse, each individually with small effects. Studies have identified a handful of robustly associated common variants. Different risk genes converge on the same mechanisms, such as gene regulation and synaptic connectivity. These mechanisms are also implicated by genes that are epigenetically and transcriptionally dysregulated in autism. Major challenges to understanding the biological mechanisms include substantial phenotypic heterogeneity, large locus heterogeneity, variable penetrance, and widespread pleiotropy. Considerable increases in sample sizes are needed to better understand the hundreds or thousands of common and rare genetic variants involved. Future research should integrate common and rare variant research, multi-omics data including genomics, epigenomics, and transcriptomics, and refined phenotype assessment with multidimensional and longitudinal measures.

Indexed as

Autism Spectrum DisorderGenomicsDNA Copy Number VariationsHumansMultifactorial InheritancePhenotypeRisk FactorsTranscriptomeTwin Studies as TopicAutismcommon variationepigeneticsgeneticsheterogeneityrare variationtranscriptomics

Identifiers

PMID33634770
PMCPMC8477228
OpenAlexW3132593238

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.